Type I nitroreductases of Escherichia coli
- PMID: 7011517
- DOI: 10.1139/m81-013
Type I nitroreductases of Escherichia coli
Abstract
Analysis of partially purified crude extract of Escherichia coli K12 by chromatography and gel electrophoresis has resulted in the separation of three distinct activities which catalyse the reduction of nitrofurazone (semicarbazone of 5-nitro-2-furaldehyde) in the presence of oxygen (type I nitroreductases). The major enzymatic activity (type IA), which was dependent solely on NADPH as a cofactor, was absent from nitrofurazone-resistant strains NFR 402 and NFR 502, but present in SIL 41, a strain which is only marginally resistant to the nitrofuran. The remaining nitroreductase activities (IB1 and IB2) utilize either NADH or NADPH as a cofactor. These activities coelute from DEAE-cellulose at pH 7.2, but may be differentiated by their behaviour on CM-cellulose at pH 5.8. The reductase activity missing in SIL 41 was observed in extracts of strain NFR 402 but not NFR 502. This enzyme (IB1) though retained by DEAE-cellulose had no affinity for CM-cellulose. The only reductase present in extracts of NFR 502 (a nitrofuran-resistant strain selected after two mutational events) was type IB2. This activity, also detectable in SIL 41 and NFR 402, has not been mapped genetically. An interesting feature of the type IB2 enzyme is its apparent inactivation by MnCl2 which has been routinely used as a partial purification step in the past.
Similar articles
-
Studies on oxygen-insensitive nitrofuran reductase in Escherichia coli B/r.J Biochem. 1981 Mar;89(3):855-9. doi: 10.1093/oxfordjournals.jbchem.a133268. J Biochem. 1981. PMID: 7026544
-
A comparative study on 1-nitropyrene and nitrofurazone reductases in Escherichia coli.J Pharmacobiodyn. 1984 Jun;7(6):407-13. doi: 10.1248/bpb1978.7.407. J Pharmacobiodyn. 1984. PMID: 6384469
-
Studies on cis-trans isomerization of nitrofuran derivatives by bacterial nitroreductases.J Pharmacobiodyn. 1984 Aug;7(8):570-6. doi: 10.1248/bpb1978.7.570. J Pharmacobiodyn. 1984. PMID: 6392502
-
An update on derivatisation and repurposing of clinical nitrofuran drugs.Eur J Pharm Sci. 2019 Dec 1;140:105092. doi: 10.1016/j.ejps.2019.105092. Epub 2019 Oct 18. Eur J Pharm Sci. 2019. PMID: 31634556 Review.
-
Mutagenicity of nitrofuran derivatives: review.Environ Mutagen. 1983;5(5):745-65. doi: 10.1002/em.2860050512. Environ Mutagen. 1983. PMID: 6311528 Review. No abstract available.
Cited by
-
Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle-directed enzyme prodrug therapy as a novel approach to cancer treatment.Microbiologyopen. 2020 Oct;9(10):e1110. doi: 10.1002/mbo3.1110. Epub 2020 Sep 26. Microbiologyopen. 2020. PMID: 32979040 Free PMC article.
-
Nitrofurantoin-resistant mutants of Escherichia coli: isolation and mapping.Mol Gen Genet. 1984;196(2):379-80. doi: 10.1007/BF00328076. Mol Gen Genet. 1984. PMID: 6387400
-
Chemoselective nitro group reduction and reductive dechlorination initiate degradation of 2-chloro-5-nitrophenol by Ralstonia eutropha JMP134.Appl Environ Microbiol. 1999 Jun;65(6):2317-23. doi: 10.1128/AEM.65.6.2317-2323.1999. Appl Environ Microbiol. 1999. PMID: 10347008 Free PMC article.
-
Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.Antimicrob Agents Chemother. 2021 Feb 17;65(3):e00858-20. doi: 10.1128/AAC.00858-20. Print 2021 Feb 17. Antimicrob Agents Chemother. 2021. PMID: 33361301 Free PMC article.
-
Vibrio harveyi nitroreductase is also a chromate reductase.Appl Environ Microbiol. 2003 Aug;69(8):4390-5. doi: 10.1128/AEM.69.8.4390-4395.2003. Appl Environ Microbiol. 2003. PMID: 12902220 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous